Complete corporate restructure - small biotech play and supposed cash cow in the form of outdoor advertising ( eyecorp anyone). They may see some interest from this restructure.
Personally, I feel the companies a joke and like HIH will probably end up under intense scrutionary for its actions.
Largest shareholder has effectively offloaded another dud to PAI. Was this an "arms lenght transaction ?" leave that to ASIC.
They should have split the cash balance of 12,000,000 back to the 40,000,000 holders - appoligised and sodded off.
Well having bought at 0.50 on float - its wait and see just how long they can draw their salaries and " attempt to build shareholder value."
